Qnovia, formerly known as Respira Technologies, is a platform pharmaceutical company dedicated to saving lives. With a mission to make a positive impact, Qnovia has developed a groundbreaking inhaled drug delivery platform that effectively administers a wide range of pharmaceuticals. This innovative technology goes beyond being a conventional medical device; it is a versatile platform with numerous applications that have the potential to transform the lives of billions of people.

By overcoming the limitations of traditional drug delivery systems, Qnovia's proprietary inhalation-based technology aims to enhance patient outcomes. Their platform optimizes and tracks dosing, increases efficacy, and improves patient compliance, all while catering to the human factors patients desire. Currently pursuing FDA approval, Qnovia is focused on addressing the world's largest preventable cause of death and disease: smoking.

With more than eight million lives lost to tobacco use each year, Qnovia aims to help the one billion smokers worldwide quit smoking for good. Qnovia is committed to redefining the standard of effective, inhaled drug delivery through strategic partnerships with leading healthcare companies. By doing so, they have the potential to improve existing therapies' efficacy and introduce new inhaled treatments to patients.

Reach out to Qnovia today to learn more about their life-saving platform and join their mission to revolutionize the healthcare industry